MorphoSys

MorphoSys's reported carbon emissions

In 2025, MorphoSys reported total carbon emissions of approximately 34.5 million kg CO2e. This figure includes Scope 1 emissions of about 964,000 kg CO2e, Scope 2 emissions of approximately 88,000 kg CO2e (market-based), and a significant contribution from Scope 3 emissions, which totalled around 33.4 million kg CO2e. The largest components of Scope 3 emissions were from purchased goods and services, accounting for about 26.6 million kg CO2e. In 2024, the company’s total emissions were approximately 49.3 million kg CO2e, with Scope 1 emissions at about 1,053,000 kg CO2e, Scope 2 emissions at approximately 114,000 kg CO2e (market-based), and Scope 3 emissions reaching around 48.1 million kg CO2e. Again, purchased goods and services were the primary contributor to Scope 3 emissions. For 2023, MorphoSys reported total emissions of approximately 18.9 million kg CO2e, with Scope 1 emissions of about 101,820 kg CO2e, Scope 2 emissions of approximately 1,340 kg CO2e (market-based), and Scope 3 emissions at around 18.8 million kg CO2e. MorphoSys has not set specific reduction targets or initiatives as per the available data. The company is part of a corporate family relationship with Novartis AG, which influences its climate commitments and reporting. Emissions data and climate initiatives may be cascaded from Novartis AG, reflecting a broader commitment to sustainability within the merged entity framework.